"After our initial meeting, we knew that Conditas' methods and professional connections would substantially assist BetaStem in our path to clinical trials.
http://www.businesswire.com/news/home/20130718005041/en/BetaStem-Therapeutics-Retains-Conditas-Biotechnology-Group-Business
http://www.businesswire.com/news/home/20130718005041/en/BetaStem-Therapeutics-Retains-Conditas-Biotechnology-Group-Business
No comments:
Post a Comment